1887

Abstract

The emergence of drug-resistant strains of influenza virus has catalysed a search for new antiviral agents to supplement or replace existing drugs. Following the success of the human immunodeficiency virus entry blocker Enfuvirtide, there has been a resurgence of interest in peptide-based antivirals. In this paper, we report on the discovery of a novel family of peptides (FluPep, FP) that function as inhibitors of influenza A virus infection. The prototype peptide (FP1, also known as Tkip) interacts with haemagglutinin and inhibits the binding of the virus to cell membranes. Using a plaque-reduction assay, we have demonstrated that a variety of influenza A virus subtypes (including H1N1, H3N2 and H5N1) are inhibited by FluPep and its derivatives at nanomolar concentrations. By truncating FluPep we have identified a minimal sequence of 6 aa that binds to haemagglutinin and inhibits infection. Using a mouse model of intranasal influenza virus infection, we observed potent inhibition of virus infection when peptide is given at the time of virus administration. These data indicate that FluPep is a highly effective anti-influenza agent with the potential to translate to the clinic.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.038679-0
2012-05-01
2020-01-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/5/980.html?itemId=/content/journal/jgv/10.1099/vir.0.038679-0&mimeType=html&fmt=ahah

References

  1. Ahmed C. M. , Dabelic R. , Waiboci L. W. , Jager L. D. , Heron L. L. , Johnson H. M. . ( 2009; ). SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system. . J Virol 83:, 1402–1415. [CrossRef] [PubMed]
    [Google Scholar]
  2. Altmann S. E. , Jones J. C. , Schultz-Cherry S. , Brandt C. R. . ( 2009; ). Inhibition of vaccinia virus entry by a broad spectrum antiviral peptide. . Virology 388:, 248–259. [CrossRef] [PubMed]
    [Google Scholar]
  3. Bai F. , Town T. , Pradhan D. , Cox J. , Ashish , Ledizet M. , Anderson J. F. , Flavell R. A. , Krueger J. K. . & other authors ( 2007; ). Antiviral peptides targeting the West Nile virus envelope protein. . J Virol 81:, 2047–2055. [CrossRef] [PubMed]
    [Google Scholar]
  4. Budge P. J. , Graham B. S. . ( 2004; ). Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses. . J Antimicrob Chemother 54:, 299–302. [CrossRef] [PubMed]
    [Google Scholar]
  5. Cheng G. , Montero A. , Gastaminza P. , Whitten-Bauer C. , Wieland S. F. , Isogawa M. , Fredericksen B. , Selvarajah S. , Gallay P. A. . & other authors ( 2008; ). A virocidal amphipathic α-helical peptide that inhibits hepatitis C virus infection in vitro . . Proc Natl Acad Sci U S A 105:, 3088–3093. [CrossRef] [PubMed]
    [Google Scholar]
  6. Cooper D. A. , Lange J. M. . ( 2004; ). Peptide inhibitors of virus-cell fusion: enfuvirtide as a case study in clinical discovery and development. . Lancet Infect Dis 4:, 426–436. [CrossRef] [PubMed]
    [Google Scholar]
  7. Howard W. , Hayman A. , Lackenby A. , Whiteley A. , Londt B. , Banks J. , McCauley J. , Barclay W. . ( 2007; ). Development of a reverse genetics system enabling the rescue of recombinant avian influenza virus A/Turkey/England/50-92/91 (H5N1). . Avian Dis 51: (Suppl.), 393–395. [CrossRef] [PubMed]
    [Google Scholar]
  8. Jing X. , Ma C. , Ohigashi Y. , Oliveira F. A. , Jardetzky T. S. , Pinto L. H. , Lamb R. A. . ( 2008; ). Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel. . Proc Natl Acad Sci U S A 105:, 10967–10972. [CrossRef] [PubMed]
    [Google Scholar]
  9. Jones J. C. , Turpin E. A. , Bultmann H. , Brandt C. R. , Schultz-Cherry S. . ( 2006; ). Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. . J Virol 80:, 11960–11967. [CrossRef] [PubMed]
    [Google Scholar]
  10. Matthews T. , Salgo M. , Greenberg M. , Chung J. , DeMasi R. , Bolognesi D. . ( 2004; ). Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes. . Nat Rev Drug Discov 3:, 215–225. [CrossRef] [PubMed]
    [Google Scholar]
  11. Mujtaba M. G. , Flowers L. O. , Patel C. B. , Patel R. A. , Haider M. I. , Johnson H. M. . ( 2005; ). Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form. . J Immunol 175:, 5077–5086.[PubMed] [CrossRef]
    [Google Scholar]
  12. Sleeman K. , Mishin V. P. , Deyde V. M. , Furuta Y. , Klimov A. I. , Gubareva L. V. . ( 2010; ). In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses. . Antimicrob Agents Chemother 54:, 2517–2524. [CrossRef] [PubMed]
    [Google Scholar]
  13. Thompson W. W. , Shay D. K. , Weintraub E. , Brammer L. , Bridges C. B. , Cox N. J. , Fukuda K. . ( 2004; ). Influenza-associated hospitalizations in the United States. . JAMA 292:, 1333–1340. [CrossRef] [PubMed]
    [Google Scholar]
  14. Triana-Baltzer G. B. , Gubareva L. V. , Nicholls J. M. , Pearce M. B. , Mishin V. P. , Belser J. A. , Chen L. M. , Chan R. W. , Chan M. C. . & other authors ( 2009; ). Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. . PLoS ONE 4:, e7788. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.038679-0
Loading
/content/journal/jgv/10.1099/vir.0.038679-0
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error